Key facts
- This page summarizes Derek Sammann's Form 4 filing for CME GROUP INC. (CME).
- 7 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2026, 16:25.
Derek Sammann - 15 Sep 2026 Form 4 Insider Report for CME GROUP INC. (CME)
- Reporting relationship
- Sr MD Gl Hd Commodities Mkts
- Issuer ticker
- CME
- Reported as of
- 15 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 16:25:59 UTC
- Prior SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Hensen, as Attorney-in-Fact for Derrek Sammann
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Derek Sammann filed Form 4 for CME GROUP INC. (CME) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 17 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001475318
Primary reporting owner
Sammann Derek
- Relationship
- Sr MD Gl Hd Commodities Mkts
- Address
- 20 S. WACKER DRIVE, CHICAGO
- Signature
- /s/ Elizabeth Hensen, as Attorney-in-Fact for Derrek Sammann
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CME
transaction
Common Stock Class A
Other
- Transaction value
- Shares
- -4,629
- Change %
- -35%
- Price
- $0.000000*
- Shares after
- 8,683
- Date
- 25 May 2026
- Ownership
- Direct
- Footnotes
- F1
CME
transaction
Common Stock Class A
Other
- Transaction value
- Shares
- +4,629
- Change %
- +42%
- Price
- $0.000000*
- Shares after
- 15,657
- Date
- 25 May 2026
- Ownership
- by Trust
- Footnotes
- F1
CME
transaction
Common Stock Class A
Award
- Transaction value
- Shares
- +2,864
- Change %
- +33%
- Price
- $275.09*
- Shares after
- 11,547
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F2
CME
transaction
Common Stock Class A
Tax liability
- Transaction value
- Shares
- -373
- Change %
- -3.2%
- Price
- $275.09*
- Shares after
- 11,174
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F3
CME
transaction
Common Stock Class A
Tax liability
- Transaction value
- Shares
- -361
- Change %
- -3.2%
- Price
- $275.09*
- Shares after
- 10,813
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F3
CME
transaction
Common Stock Class A
Tax liability
- Transaction value
- Shares
- -320
- Change %
- -3%
- Price
- $275.09*
- Shares after
- 10,493
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F3
CME
transaction
Common Stock Class A
Tax liability
- Transaction value
- Shares
- -359
- Change %
- -3.4%
- Price
- $272.46*
- Shares after
- 10,134
- Date
- 16 Sep 2026
- Ownership
- Direct
- Footnotes
- F3
CME
holding
Common Stock Class A
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,022
- Date
- 15 Sep 2026
- Ownership
- by Spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934.
Footnote F2
Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
Footnote F3
Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.